谜题中的新线索：β-干扰素在多发性硬化症中究竟是如何发挥作用的？ - Suppr

New pieces in the puzzle: how does interferon-beta really work in multiple sclerosis?

作者信息

Mitsdoerffer Meike, Kuchroo Vijay

出版信息

Ann Neurol. 2009 May;65(5):487-8. doi: 10.1002/ana.21722.

DOI:10.1002/ana.21722

PMID:19479722

Abstract

摘要

相似文献

New pieces in the puzzle: how does interferon-beta really work in multiple sclerosis?

Ann Neurol. 2009 May;65(5):487-8. doi: 10.1002/ana.21722.

[Semaphorin 4 in multiple sclerosis].

Nihon Rinsho. 2015 Sep;73 Suppl 7:821-5.

Is the decrease in suppressor inducer T cells in multiple sclerosis specific?

Ann Neurol. 1990 Apr;27(4):447-8. doi: 10.1002/ana.410270416.

[Behavior of T lymphocytes, T helper and T suppressor, in multiple sclerosis. Preliminary report].

Rev Paul Med. 1984 Jul-Aug;102(4):181-3.

IFN-beta inhibits human Th17 cell differentiation.

J Immunol. 2009 Oct 15;183(8):5418-27. doi: 10.4049/jimmunol.0803227. Epub 2009 Sep 25.

Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.

Nat Med. 2008 Jun;14(6):614-5. doi: 10.1038/nm0608-614.

Helper/suppressor ratio in multiple sclerosis.

Ir Med J. 1984 Apr;77(4):119.

T helper/suppressor ratio and acute attacks in multiple sclerosis.

Ir Med J. 1984 Feb;77(2):39-41.

Molecular oracles for multiple sclerosis therapy.

Nat Med. 2010 Apr;16(4):376-7. doi: 10.1038/nm0410-376.

Interferon-beta therapy for multiple sclerosis--is the injection site the relevant action site?

J Neuroimmunol. 2009 Oct 30;215(1-2):117-21. doi: 10.1016/j.jneuroim.2009.08.011. Epub 2009 Sep 20.

引用本文的文献

The immunology of multiple sclerosis.

Nat Rev Immunol. 2022 Dec;22(12):734-750. doi: 10.1038/s41577-022-00718-z. Epub 2022 May 4.

RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis.

Front Immunol. 2018 May 31;9:1235. doi: 10.3389/fimmu.2018.01235. eCollection 2018.

Multiple Sclerosis: Immunopathology and Treatment Update.

Brain Sci. 2017 Jul 7;7(7):78. doi: 10.3390/brainsci7070078.

CpG Type A Induction of an Early Protective Environment in Experimental Multiple Sclerosis.

Mediators Inflamm. 2017;2017:1380615. doi: 10.1155/2017/1380615. Epub 2017 Mar 5.

Selective depletion of CD11c CD11b dendritic cells partially abrogates tolerogenic effects of intravenous MOG in murine EAE.

Eur J Immunol. 2016 Oct;46(10):2454-2466. doi: 10.1002/eji.201546274.

Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.

Nat Med. 2016 Jun;22(6):586-97. doi: 10.1038/nm.4106. Epub 2016 May 9.

Role and therapeutic value of dendritic cells in central nervous system autoimmunity.

Cell Death Differ. 2015 Feb;22(2):215-24. doi: 10.1038/cdd.2014.125. Epub 2014 Aug 29.

IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39.

Nat Immunol. 2013 Oct;14(10):1054-63. doi: 10.1038/ni.2695. Epub 2013 Sep 1.

Interleukin 17F level and interferon β response in patients with multiple sclerosis.

JAMA Neurol. 2013 Aug;70(8):1017-21. doi: 10.1001/jamaneurol.2013.192.

[Interferon-β1b in multiple sclerosis therapy: more than 20 years clinical experience].

Nervenarzt. 2013 Jun;84(6):679-704. doi: 10.1007/s00115-013-3781-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

New pieces in the puzzle: how does interferon-beta really work in multiple sclerosis?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献